Resurfaced shape complementary proteins that selectively bind the oncoprotein gankyrin

ACS Chemical Biology

Volumn 9, Issue 10, 2014, Pages 2223-2228

  Chapman, Alex M ^a   McNaughton, Brian R ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; GANKYRIN; GREEN FLUORESCENT PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; PROTEASOME; PSMD10 PROTEIN, HUMAN;

ARTICLE; BINDING AFFINITY; CELL FUNCTION; CELL LYSATE; DISSOCIATION CONSTANT; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; NONHUMAN; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; THERMOSTABILITY; DIFFERENTIAL SCANNING CALORIMETRY; FLOW CYTOMETRY; GENETICS; HUMAN; METABOLISM; MUTATION; PROTEIN CONFORMATION; PROTEIN DOMAIN;

CALORIMETRY, DIFFERENTIAL SCANNING; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HUMANS; MEMBRANE PROTEINS; MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTO-ONCOGENE PROTEINS;

EID: 84908367068     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb5003834     Document Type: Article

References (33)

1. Stockwell, B. R. (2000) Chemical genetics: ligand-based discovery of gene function. Nat. Rev. Genet. 1, 116-125.
2. Stockwell, B. R. (2000) Frontiers in chemical genetics. Trends Biotechnol. 18, 449-455.
3. Overington, J. P., Al-Lazikani, B., and Hopkins, A. L. (2006) How many drug targets are there? Nat. Rev. Drug Discovery 5, 993-996.
4. Li, J., Mahajan, A., and Tsai, M. D. (2006) Ankyrin repeat: a unique motif mediating protein-protein interactions. Biochemistry 45, 15168-15178.
5. Kim, Y. H., Kim, J. H., Choi, Y. W., Lim, S. K., Yim, H., Kang, S. Y., Chung, Y. S., Lee, G. Y., and Park, T. J. (2013) Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression. Exp. Mol. Pathol. 94, 360-365.
6. Zhen, C., Chen, L., Zhao, Q., Liang, B., Gu, Y. X., Bai, Z. F., Wang, K., Xu, X., Han, Q. Y., Fang, D. F., Wang, S. X., Zhou, T., Xia, Q., Gong, W. L., Wang, N., Li, H. Y., Jin, B. F., and Man, J. H. (2013) Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity. Oncogene 32, 3452-3460.
7. Fu, X. Y., Wang, H. Y., Tan, L., Liu, S. Q., Cao, H. F., and Wu, M. C. (2002) Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance. World J. Gastroenterol. 8, 638-643.
8. Li, J., Knobloch, T. J., Kresty, L. A., Zhang, Z., Lang, J. C., Schuller, D. E., and Weghorst, C. M. (2011) Gankyrin, a biomarker for epithelial carcinogenesis, is overexpressed in human oral cancer. Anticancer Res. 31, 2683-2692.
9. Meng, Y., He, L., Guo, X., Tang, S., Zhao, X., Du, R., Jin, J., Bi, Q., Li, H., Nie, Y., Liu, J., and Fan, D. (2010) Gankyrin promotes the proliferation of human pancreatic cancer. Cancer Lett. 297, 9-17.
10. Tang, S., Yang, G., Meng, Y., Du, R., Li, X., Fan, R., Zhao, L., Bi, Q., Jin, J., Gao, L., Zhang, L., Li, H., Fan, M., Wang, Y., Wu, K., Liu, J., and Fan, D. (2010) Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer. Cancer Biol. Ther. 9, 88-95.
11. Ortiz, C. M., Ito, T., Tanaka, E., Tsunoda, S., Nagayama, S., Sakai, Y., Higashitsuji, H., Fujita, J., and Shimada, Y. (2008) Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance. Int. J. Cancer 122, 325-332.
12. Man, J. H., Liang, B., Gu, Y. X., Zhou, T., Li, A. L., Li, T., Jin, B. F., Bai, B., Zhang, H. Y., Zhang, W. N., Li, W. H., Gong, W. L., Li, H. Y., and Zhang, X. M. (2010) Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells. J. Clin. Invest. 120, 2829-2841.
13. Li, J. N., and Tsai, M. D. (2002) Novel insights into the INK4-CDK4/6-Rb pathway: Counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb. Biochemistry 41, 3977-3983.
14. Higashitsuji, H., Higashitsuji, H., Itoh, K., Sakurai, T., Nagao, T., Sumitomo, Y., Masuda, T., Dawson, S., Shimada, Y., Mayer, R. J., and Fujita, J. (2005) The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53 (vol 8, pg 75, 2005). Cancer Cell No. 8, 169-169.
15. Nakamura, Y., Nakano, K., Umehara, T., Kimura, M., Hayashizaki, Y., Tanaka, A., Horikoshi, M., Padmanabhan, B., and Yokoyama, S. (2007) Structure of the oncoprotein gankyrin in complex with S6 ATPase of the 26S proteasome. Structure 15, 179-189.
16. Higashitsuji, H., Itoh, K., Nagao, T., Dawson, S., Nonoguchi, K., Kido, T., Mayer, R. J., Arii, S., and Fujita, J. (2000) Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat. Med. 6, 96-99.
17. Jones, S., and Thornton, J. M. (1996) Principles of protein-protein interactions. Proc. Natl. Acad. Sci., U.S.A. 93, 13-20.
18. Abdel-Rahman, N., Martinez-Arias, A., and Blundell, T. L. (2011) Probing the druggability of protein-protein interactions: targeting the Notch1 receptor ankyrin domain using a fragment-based approach. Biochem. Soc. Trans. 39, 1327-1333.
19. Cronican, J. J., Beier, K. T., Davis, T. N., Tseng, J. C., Li, W., Thompson, D. B., Shih, A. F., May, E. M., Cepko, C. L., Kung, A. L., Zhou, Q., and Liu, D. R. (2011) A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivo. Chem. Biol. 18, 833-838.
20. Cronican, J. J., Thompson, D. B., Beier, K. T., McNaughton, B. R., Cepko, C. L., and Liu, D. R. (2010) Potent delivery of functional proteins into mammalian cells in vitro and in vivo using a supercharged protein. ACS Chem. Biol. 5, 747-752.
21. DePorter, S. M., Lui, I., Bruce, V. J., Gray, M. A., Lopez-Islas, M., and McNaughton, B. R. (2014) Mutagenesis modulates the uptake efficiency, cell-selectivity, and functional enzyme delivery of a protein transduction domain. Mol. BioSyst. 10, 18-23.
22. DePorter, S. M., Lui, I., Mohan, U., and McNaughton, B. R. (2013) A protein transduction domain with cell uptake and selectivity profiles that are controlled by multivalency effects. Chem. Biol. 20, 434-444.
23. Deshayes, S., Morris, M. C., Divita, G., and Heitz, F. (2005) Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell. Mol. Life. Sci. 62, 1839-1849.
24. Fuchs, S. M., and Raines, R. T. (2005) Polyarginine as a multifunctional fusion tag. Protein Sci. 14, 1538-1544.
25. Fuchs, S. M., and Raines, R. T. (2007) Arginine grafting to endow cell permeability. ACS Chem. Biol. 2, 167-170.
26. Burton, D. R., and Weiss, R. A. (2010) A boost for HIV vaccine design. Science 329, 770-773.
27. Karanicolas, J., Corn, J. E., Chen, I., Joachimiak, L. A., Dym, O., Peck, S. H., Albeck, S., Unger, T., Hu, W., Liu, G., Delbecq, S., Montelione, G. T., Spiegel, C. P., Liu, D. R., and Baker, D. (2011) A de novo protein binding pair by computational design and directed evolution. Mol. Cell 42, 250-260.
28. Blakeley, B. D., Chapman, A. M., and McNaughton, B. R. (2012) Split-superpositive GFP reassembly is a fast, efficient, and robust method for detecting protein-protein interactions in vivo. Mol. BioSyst. 8, 2036-2040.
29. Magliery, T. J., and Regan, L. (2006) Reassembled GFP: detecting protein-protein interactions and protein expression patterns. Methods Biochem. Anal. 47, 391-405.
30. Magliery, T. J., Wilson, C. G., Pan, W., Mishler, D., Ghosh, I., Hamilton, A. D., and Regan, L. (2005) Detecting protein-protein interactions with a green fluorescent protein fragment reassembly trap: scope and mechanism. J. Am. Chem. Soc. 127, 146-157.
31. Wilson, C. G., Magliery, T. J., and Regan, L. (2004) Detecting protein-protein interactions with GFP-fragment reassembly. Nat. Methods 1, 255-262.
32. Lawrence, M. S., Phillips, K. J., and Liu, D. R. (2007) Supercharging proteins can impart unusual resilience. J. Am. Chem. Soc. 129, 10110-10112.
33. For a similar pull-down experiment, see Root, M. J., Kay, M. S., and Kim, P. S. (2001) Protein design of an HIV-1 entry inhibitor. Science 291, 884-888.